ADAP · Categories · 8-K
ADAP - SEC Form 8-K filings
Adaptimmune Therapeutics plc (ADAP) sec form 8-k filings - real-time wire coverage filtered to 8-K only.
Recent 8-K for ADAP
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Other Events8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)8-K/A - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- SEC Form 8-K filed by Adaptimmune Therapeutics plc8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Other Events8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)
- Adaptimmune Therapeutics plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adaptimmune Therapeutics PLC (0001621227) (Filer)